{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-21-000377","form_type":"8-K","ticker":"CHE","cik":"0000019584","company_name":"CHEMED CORP","filed_at":"2021-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.968289+00:00","generated_at":"2026-06-28T17:00:11.074746+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Chemed Q3 adj. EPS $5.06 (+4.1%), revenue $539M (+2%); FY21 guidance raised to $19.00-$19.20","bullets":["Repurchased 350,000 shares for $164M; $148M remaining authorization; no long-term debt.","VITAS revenue -5.8% to $317M, ADC -5.3%; Roto-Rooter revenue +15.7% to $221M.","Roto-Rooter adjusted EBITDA margin 29.7% (+266 bps); VITAS margin 19.0% (-146 bps).","Full-year 2021 adjusted EPS guidance raised to $19.00-$19.20 from prior $17.00-$17.50.","Adjusted diluted EPS of $5.06 beats prior-year $4.86; GAAP EPS $4.55."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-21-000377","json":"https://secwatch.observer/filing/0001562762-21-000377.json","markdown":"https://secwatch.observer/filing/0001562762-21-000377.md","text":"https://secwatch.observer/filing/0001562762-21-000377.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/19584/000156276221000377/0001562762-21-000377-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/19584/000156276221000377/che-20211028x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T17:00:11.074746+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}